Dr. Holder is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
7720 US Highway 98 W
Ste 110
Miramar Beach, FL 32550Fax+1 850-622-3342
Summary
- Kevin Holder, MD, is a Cardiologist based in Tallahassee, FL. He completed his residency in Internal Medicine at Tulane University (2005-2008) and a fellowship in Cardiovascular Disease at Oregon Health & Science University (2008-2011). His education began at Brody School of Medicine at East Carolina University, from where he graduated in 2005. Dr. Holder has several publications in esteemed medical journals, including The Journal of Biological Chemistry and JAMA. His research has been widely cited, emphasizing his contribution to the field. He was honored with the Meaningful Use Stage 1 Certification from the Centers for Medicare & Medicaid Services in 2012.
Education & Training
- Oregon Health & Science University (OHSU Health)Fellowship, Cardiovascular Disease, 2008 - 2011
- Tulane UniversityResidency, Internal Medicine, 2005 - 2008
- Brody School of Medicine at East Carolina UniversityClass of 2005
Certifications & Licensure
- OR State Medical License 2009 - Present
- FL State Medical License 2017 - 2026
- NC State Medical License 2019 - 2023
- TN State Medical License 2020 - 2022
- WA State Medical License 2011 - 2018
- LA State Medical License 2006 - 2009
- American Board of Internal Medicine Cardiovascular Disease
- Certification Board of Nuclear CardiologyDiplomate
- National Board of EchocardiographyDiplomate- Adult Comprehensive Echocardiography
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Publications & Presentations
PubMed
- 22 citationsThiazolidinediones Up-regulate Insulin-like Growth Factor-1 Receptor via a Peroxisome Proliferator-activated Receptor γ-Independent PathwayYusuke Higashi, Kevin N. Holder, Patrice Delafontaine
The Journal of Biological Chemistry. 2010-11-19 - 141 citationsRequirement of HDAC6 for Transforming Growth Factor-β1-induced Epithelial-Mesenchymal TransitionBin Shan, Tso-Pang Yao, Hong T. Nguyen, Ying Zhuo, Dawn R. Levy
The Journal of Biological Chemistry. 2008-07-25 - 285 citationsEffect of folic acid supplementation on risk of cardiovascular diseases: a meta-analysis of randomized controlled trials.Lydia A. Bazzano, Kristi Reynolds, Kevin N. Holder, Jiang He
JAMA. 2006-12-13
Abstracts/Posters
- Potential Mechanism for Atheroprotective Effects of Thiazolidinediones: Upregulation of Vascular Smooth Muscle Insulin-Like Growth Factor-1 Receptor Expression and Sig...Higashi,Y., Holder, K., Delafontaine, P., The Endocrine Society's 89th Annual Meeting, Toronto, 6/2007
- Epstein-Barr Virus Latent Membrane Protein-1 Induces Epithelial-Mesenchymal Transition by Acting Synergistically with Transforming Growth Factor-1 in Human Lung Epithe...R.C. Klingsberg, MD, J.A. Lasky, MD, E. Flemington, PhD, H.T. Nguyen, B.S., Y. Zhou, MD, K. Holder, MD and B. Shan, PhD, American Thoracic Society International Conference, 1/1/2007
- A Novel Anti-Atherosclerotic Effect of the Thiazolidinedione Class of Peroxisome Proliferator Activated Receptor gamma Ligands: Upregulation of Vascular Smooth Muscle ...Higashi Yuske, Holder Kevin, Delafontaine Patrick, Circulation. 2006, Oct 31 Supplemental Issue, AHA Scientific Sessions, 10/31/2006
Press Mentions
- Briefcase: March 8March 8th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: